FDA NDC Directory · JSON-LD · Markdown

Lyfgenia

NDC 73554-1111 · CELLULAR THERAPY · SUSPENSION

Generic namelovotibeglogene autotemcel
Labeler / ManufacturerGenetix Biotherapeutics Inc.
Marketing categoryBiologic License Application · App BLA125788
Dosage form / routeSUSPENSION · INTRAVENOUS
Active ingredientsLOVOTIBEGLOGENE AUTOTEMCEL (20000000 1/20mL)
Marketing started20231208
Package count1

External sources

Source: openFDA. Public-domain (CC0).